The work of the EMCDDA is underpinned by two long-term goals: to contribute to a healthier Europe and to a more secure Europe. To achieve our mission, we have developed a systemic approach that brings together the human networks, processes and scientifc tools necessary for collecting, analysing and reporting on all aspects of the European drugs phenomenon. This page is designed to be a window onto the agency's work. The aspects presented below are grouped in broad working areas but in reality activities are complementary and frequently overlap.
For an overview of the EMCDDA's course of travel to 2025, see EMCDDA Strategy 2025. For a detailed view of the agency's work by year, please see our General report of activities.
Communicating evidence and knowledge exchange
The most tangible results of the agency's work are its products and publications. The links below provide quick access to some key outputs (others are listed according to the most appropriate working areas).
The EMCDDA supports drug policy dialogue at EU level by providing expertise and technical information to the EU institutions, as well as by maintaining communication with the Member States. The links below provide some additional information on this important activity.
The EMCDDA's support to practice involves the dissemination of best practice and the design and implementation of capacity-building and training initiatives for different audiences. The links below cover various aspects of this key activity.
Ensuring scientific excellence
Quality assurance at every stage of the EMCDDA's scientific work is of critical importance for the agency.
Responding to new psychoactive substances (NPS)
With its partners in Member States, Europol and the European Medicines Agency (EMA), the EMCDDA is responsible for ensuring the continuous and robust implementation of the Early Warning System on the information exchange, risk assessment and control of new psychoactive substances (NPS).
Identifying and tracking emerging trends and threats
The detection and monitoring of new trends and threats is one of the EMCDDA's key tasks. The agency is proactively involved in the development of innovative systems for identifying and tracking new and emerging trends.
Monitoring and analysing situation, responses and trends
This area encompasses the core monitoring and analysis activities of the EMCDDA. These activities are based on established tools and processes (such as the key epidemiological indicators) complemented by the development of new ones as necessary.
Cooperation with international and national partners
Cooperation with EU, national, and international partners is of key strategic importance to the EMCDDA. These partners include the Reitox network of national focal points, EU bodies, international organisations, neighbouring and candidate countries.